Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Preanalytical Impacts on Protein Detection by HumanMap assay

ABSTRACT: Preanalytical Impacts on Protein Detection by HumanMap assay

PROVIDER: PRJNA701505 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

TOP1cc-seq assay in human cancer cells

Project description:TOP1cc-seq assay was performed for the quantitative detection of the transient DNA-protein covalent interactions upon acute stimulations.

2022-08-04 | GSE135723 | GEO

Preanalytical Impacts on Copy Number Variation Detection by aCGH Technology

Project description:Preanalytical Impacts on Copy Number Variation Detection by aCGH Technology

| PRJNA477670 | ENA

Preanalytical impacts on protein stability by IHC evaluation

Project description:Preanalytical impacts on protein stability by IHC evaluation

| PRJNA701506 | ENA

In situ detection and amplification of protein-protein interactions can increase recombinant protein production

Project description:In situ detection and amplification of protein-protein interactions can increase recombinant protein production

| PRJNA1254963 | ENA

ChIP-seq assay in human cancer cells

Project description:ChIP-seq assay was performed for the quantitative detection of the binding of TFs and histones upon acute stimulations.

2022-08-04 | GSE135807 | GEO

TCR and BCR loci copy number aberration detection for FFPE tissues using MIP-based assay

Project description:The classification of haematolymphoid neoplasms has important clinical implications, yet current methods to determine cell lineage on formalin-fixed paraffin-embedded (FFPE) tissues are unsatisfactory, especially for neoplasms of NK- and T-cell lineages. Herein, we performed copy number analysis using the MIP platform on 86 cases, including T-, NK- and B-cell lymphomas, malignant cell lines and normal lymphocyte subsets. We demonstrate that the loss of T- and B-cell receptor gene loci correlates with cell lineage. The overall sensitivity of the assay in our cohort was 91% and 78%, while the specificity was 84% and 93%, for the corresponding antigen receptors in T- and B-cell samples, respectively. Fluorescence in situ hybridization showed no detectable translocation or deletion of the TCRA locus in samples showing loss of TCRA. Compared to PCR-based gene arrangement assay for lineage assignment, the MIP assay showed good reliability on FFPE samples, including cases more than 10 years old. In conclusion, the detection of the loss of the antigen receptor gene loci using the MIP array is a novel genetic marker of lymphoid cell lineage and a potentially valuable tool in the diagnosis and classification of lymphoid neoplasms especially of T- and NK-cell origin.

2019-02-19 | GSE111052 | GEO

Ubiquitin-Proteasome System Dysregulation in Alzheimer's Disease Impacts Protein Abundance

Project description:Ubiquitin-Proteasome System Dysregulation in Alzheimer's Disease Impacts Protein Abundance

| PRJNA1449257 | ENA

Kentucky assay

Project description:Kentucky assay

| PRJNA610532 | ENA

Novel activity assay for botulotoxin A1 detection using functionalized chips and matrix-assisted laser desorption/ionization mass spectrometry

Project description:Botulinum neurotoxins (BoNTs) are a group of neurotoxins produced by Clostridium bacteria. Their effect on neuro-muscular connections through cleaving proteins of the SNARE complex results in blocking acetylcholine signal transduction. To prevent external intoxication by BoNT, analysis of potential sources of BoNT needs to be performed. Currently available methods target the presence of BoNTs molecules but only a fraction is screening real toxic activity. The FDA-approved mouse bioassay, based on exposing live mice to the potentially contaminated food, is the most common. Unfortunately, this assay is expensive, time consuming and ethically questionable. That is why there is a need for assays that can measure the activity of BoNTs enzymatically. We present an assay combining known EndoPep-MS assay with detection protein affinity chips manufactured by ion soft-landing technology. The toxic activity is indirectly determined by monitoring their endopeptidase activity as a change in molecular mass of cleaved substrate peptides exposed to BoNTs. Our modification utilizes a protein array modified by affinity molecules towards either the BoNTs or the substrate peptides. Both variants allow to perform the in-situ reaction and detection of substrate peptides by MALDI-ToF MS on the protein chip. This method demonstrated successful detection of active BoNT/A1 in both buffer and complex matrices, achieving a detection limit of 0.5 ng/mL.

2025-03-21 | PXD058240 | Pride

NanoString nCounter Cancer CN panel assay CNV detection of high-grade serous carcinoma samples

Project description:NanoString nCounter Cancer CN panel assay CNV detection of high-grade serous carcinoma samples

| PRJNA1022412 | ENA